CliffBio
biologic

Chorionic Gonadotropin

chorionic gonadotropin

Loss of exclusivityMarch 1985projected — 12-year biologic exclusivity estimate
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameChorionic Gonadotropin
Active ingredientchorionic gonadotropin
Strength10,000UNITS
Dosage formFor Injection
RouteIntramuscular
ModalityBiologic
FDA approvalMarch 1973
Marketing statusRx

More from Fresenius Kabi

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Chorionic Gonadotropin patent cliff — loss of exclusivity March 1985 | CliffBio